Associate Director (m/f/x), Real World Evidence (RWE) Science
Location: Amsterdam, Maidenhead, Munich
The Opportunity
Join Seqirus and play a pivotal role in shaping the future of real-world evidence generation in vaccines. As Associate Director, RWE Science, you will be a senior scientific leader within the Center of Outcomes Research and Epidemiology (CORE), driving the development and execution of global real-world research strategies that support late-stage and marketed vaccine products.
Working across a highly matrixed global environment, you will collaborate with Medical Affairs, R&D, Market Access, Regulatory Affairs, Commercial teams, and external scientific stakeholders to generate impactful evidence that informs clinical practice, supports health authority engagement, and strengthens public health outcomes worldwide.
The Role
Reporting to the Senior Director, Center of Outcomes Research and Epidemiology (CORE), you will provide scientific and methodological leadership for global real-world evidence programs and help shape the short- to medium-term RWE strategy.
Key responsibilities include:
Your Qualifications
To succeed in this role, you will bring strong scientific expertise, strategic thinking, and the ability to influence stakeholders across global functions.
Required Qualifications
Preferred Competencies
What We Offer
At Seqirus, you'll have the opportunity to contribute to a global mission focused on protecting public health through innovative vaccine solutions. You'll work alongside highly experienced scientific and medical professionals in a collaborative environment that values innovation, development, and scientific excellence.
We offer:
Join us in advancing science, improving patient outcomes, and helping protect communities worldwide.
About CSL Seqirus
CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, CSL Seqirus utilizes egg, cell and adjuvant technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .
Our Benefits
Associate Director (m/f/x), Real World Evidence (RWE) Science werkgever: CSL
CSL Behring is een uitstekende werkgever die zich richt op het verbeteren van levens door innovatieve therapieën te ontwikkelen. Met een sterke focus op inclusie en diversiteit, biedt het bedrijf een stimulerende werkomgeving waar medewerkers de kans krijgen om hun vaardigheden te ontwikkelen en bij te dragen aan belangrijke medische vooruitgangen. Werken in Breda of Mechelen betekent ook profiteren van een dynamische cultuur en uitstekende voordelen die de welzijn van medewerkers ondersteunen.